BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ajuebor MN, Hogaboam CM, Kunkel SL, Proudfoot AE, Wallace JL. The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat. J Immunol. 2001;166:552-558. [PMID: 11123336 DOI: 10.4049/jimmunol.166.1.552] [Cited by in Crossref: 99] [Cited by in F6Publishing: 102] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Baruah V, Tiwari D, Hazam RK, Bose M, Bujarbaruah D, Saikia AK, Kar P, Dutta S, Bose S. Prognostic, clinical, and therapeutic importance of RANTES-CCR5 axis in hepatitis A infection: A multiapproach study. J Med Virol 2021;93:3656-65. [PMID: 32975838 DOI: 10.1002/jmv.26557] [Reference Citation Analysis]
2 Blanchard C, Rothenberg ME. Chemotactic factors associated with eosinophilic gastrointestinal diseases. Immunol Allergy Clin North Am 2009;29:141-8, xi. [PMID: 19141349 DOI: 10.1016/j.iac.2008.10.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
3 Xu H, Firdawes S, Yamamoto A, Zhao Y, Ihara Y, Uehara S, Matsunami K, Otsuka H, Fukuzawa M, Miyagawa S. Effects of Blocking the Chemokine Receptors, CCR5 and CXCR3, With TAK-779 in a Rat Small Intestinal Transplantation Model. Transplantation 2008;86:1810-7. [DOI: 10.1097/tp.0b013e31818fe7fe] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Motavallian A, Minaiyan M, Rabbani M, Andalib S, Mahzouni P. Involvement of 5HT3 Receptors in Anti-Inflammatory Effects of Tropisetron on Experimental TNBS-Induced Colitis in Rat. Bioimpacts. 2013;3:169-176. [PMID: 24455480 DOI: 10.5681/bi.2013.021] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
5 Proudfoot AE, Power CA, Rommel C, Wells TN. Strategies for chemokine antagonists as therapeutics. Seminars in Immunology 2003;15:57-65. [DOI: 10.1016/s1044-5323(02)00128-8] [Cited by in Crossref: 70] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
6 Lapiere A, Geiger M, Robert V, Demarquay C, Auger S, Chadi S, Benadjaoud M, Fernandes G, Milliat F, Langella P, Benderitter M, Chatel JM, Sémont A. Prophylactic Faecalibacterium prausnitzii treatment prevents the acute breakdown of colonic epithelial barrier in a preclinical model of pelvic radiation disease. Gut Microbes 2020;12:1-15. [PMID: 32985332 DOI: 10.1080/19490976.2020.1812867] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Chevigné A, Fievez V, Schmit J, Deroo S. Engineering and screening the N-terminus of chemokines for drug discovery. Biochemical Pharmacology 2011;82:1438-56. [DOI: 10.1016/j.bcp.2011.07.091] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
8 Wéra O, Lancellotti P, Oury C. The Dual Role of Neutrophils in Inflammatory Bowel Diseases. J Clin Med 2016;5:E118. [PMID: 27999328 DOI: 10.3390/jcm5120118] [Cited by in Crossref: 101] [Cited by in F6Publishing: 92] [Article Influence: 20.2] [Reference Citation Analysis]
9 Liou JT, Yuan HB, Mao CC, Lai YS, Day YJ. Absence of C-C motif chemokine ligand 5 in mice leads to decreased local macrophage recruitment and behavioral hypersensitivity in a murine neuropathic pain model. Pain 2012;153:1283-91. [PMID: 22494919 DOI: 10.1016/j.pain.2012.03.008] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
10 Kwiatkowski K, Piotrowska A, Rojewska E, Makuch W, Jurga A, Slusarczyk J, Trojan E, Basta-kaim A, Mika J. Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2016;64:68-78. [DOI: 10.1016/j.pnpbp.2015.07.005] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 7.8] [Reference Citation Analysis]
11 Kashfi K. Anti-inflammatory agents as cancer therapeutics. Adv Pharmacol 2009;57:31-89. [PMID: 20230759 DOI: 10.1016/S1054-3589(08)57002-5] [Cited by in Crossref: 54] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
12 Scaldaferri F, Correale C, Gasbarrini A, Danese S. Mucosal biomarkers in inflammatory bowel disease: Key pathogenic players or disease predictors? World J Gastroenterol 2010; 16(21): 2616-2625 [PMID: 20518083 DOI: 10.3748/wjg.v16.i21.2616] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
13 Wang KW, Zhan X, McAlpine W, Zhang Z, Choi JH, Shi H, Misawa T, Yue T, Zhang D, Wang Y, Ludwig S, Russell J, Tang M, Li X, Murray AR, Moresco EMY, Turer EE, Beutler B. Enhanced susceptibility to chemically induced colitis caused by excessive endosomal TLR signaling in LRBA-deficient mice. Proc Natl Acad Sci U S A 2019;116:11380-9. [PMID: 31097594 DOI: 10.1073/pnas.1901407116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Stevenson DA, Yan J, He Y, Li H, Liu Y, Zhang Q, Jing Y, Guo Z, Zhang W, Yang D, Wu X, Hanson H, Li X, Staser K, Viskochil DH, Carey JC, Chen S, Miller L, Roberson K, Moyer-Mileur L, Yu M, Schwarz EL, Pasquali M, Yang FC. Multiple increased osteoclast functions in individuals with neurofibromatosis type 1. Am J Med Genet A 2011;155A:1050-9. [PMID: 21465658 DOI: 10.1002/ajmg.a.33965] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
15 Chopade SS, Dhaneshwar SS. Determination of the mitigating effect of colon-specific bioreversible codrugs of mycophenolic acid and aminosugars in an experimental colitis model in Wistar rats. World J Gastroenterol 2018; 24(10): 1093-1106 [PMID: 29563754 DOI: 10.3748/wjg.v24.i10.1093] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
16 Melgar S, Drmotova M, Rehnström E, Jansson L, Michaëlsson E. Local production of chemokines and prostaglandin E2 in the acute, chronic and recovery phase of murine experimental colitis. Cytokine. 2006;35:275-283. [PMID: 17088072 DOI: 10.1016/j.cyto.2006.09.007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
17 Matsui M, Weaver J, Proudfoot AE, Wujek JR, Wei T, Richer E, Trapp BD, Rao A, Ransohoff RM. Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES. Journal of Neuroimmunology 2002;128:16-22. [DOI: 10.1016/s0165-5728(02)00121-2] [Cited by in Crossref: 61] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
18 Pais R, Zietek T, Hauner H, Daniel H, Skurk T. RANTES (CCL5) reduces glucose-dependent secretion of glucagon-like peptides 1 and 2 and impairs glucose-induced insulin secretion in mice. Am J Physiol Gastrointest Liver Physiol 2014;307:G330-7. [PMID: 24875103 DOI: 10.1152/ajpgi.00329.2013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
19 Hwaiz R, Rahman M, Syk I, Zhang E, Thorlacius H. Rac1-dependent secretion of platelet-derived CCL5 regulates neutrophil recruitment via activation of alveolar macrophages in septic lung injury. Journal of Leukocyte Biology 2015;97:975-84. [DOI: 10.1189/jlb.4a1214-603r] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
20 Koenen RR, Weber C. Chemokines: established and novel targets in atherosclerosis. EMBO Mol Med. 2011;3:713-725. [PMID: 22038924 DOI: 10.1002/emmm.201100183] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 7.0] [Reference Citation Analysis]
21 Pease JE, Horuk R. CCR1 antagonists in clinical development. Expert Opinion on Investigational Drugs 2005;14:785-96. [DOI: 10.1517/13543784.14.7.785] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
22 Sharma R, Wu X, Rhodes SD, Chen S, He Y, Yuan J, Li J, Yang X, Li X, Jiang L, Kim ET, Stevenson DA, Viskochil D, Xu M, Yang FC. Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice. Hum Mol Genet. 2013;22:4818-4828. [PMID: 23863460 DOI: 10.1093/hmg/ddt333] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
23 Fedeli D, Montani M, Carloni M, Nasuti C, Amici A, Gabbianelli R. Leukocyte Nurr1 as peripheral biomarker of early-life environmental exposure to permethrin insecticide. Biomarkers 2012;17:604-9. [DOI: 10.3109/1354750x.2012.706641] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
24 Seo KS, Park JY, Davis WC, Fox LK, McGuire MA, Park YH, Bohach GA. Superantigen-mediated differentiation of bovine monocytes into dendritic cells. J Leukoc Biol 2009;85:606-16. [PMID: 19129485 DOI: 10.1189/jlb.0608338] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
25 Demoule A, Divangahi M, Yahiaoui L, Danialou G, Gvozdic D, Petrof BJ. Chemokine receptor and ligand upregulation in the diaphragm during endotoxemia and Pseudomonas lung infection. Mediators Inflamm 2009;2009:860565. [PMID: 19421418 DOI: 10.1155/2009/860565] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
26 Fodil N, Moradin N, Leung V, Olivier JF, Radovanovic I, Jeyakumar T, Flores Molina M, McFarquhar A, Cayrol R, Bozec D, Shoukry NH, Kubo M, Dimitrieva J, Louis E, Theatre E, Dahan S, Momozawa Y, Georges M, Yeretssian G, Gros P. CCDC88B is required for pathogenesis of inflammatory bowel disease. Nat Commun 2017;8:932. [PMID: 29030607 DOI: 10.1038/s41467-017-01381-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
27 Johnson R, Wood N, Serio F. Interleukin-11 and IL-17 and the Pathogenesis of Periodontal Disease. Journal of Periodontology 2004;75:37-43. [DOI: 10.1902/jop.2004.75.1.37] [Cited by in Crossref: 126] [Cited by in F6Publishing: 126] [Article Influence: 7.4] [Reference Citation Analysis]
28 Vrablicova Z, Soltys K, Krajcovicova A, Stuchlikova K, Sturdik I, Koller T, Huorka M, Payer J, Killinger Z, Jackuliak P, Tkacik M, Stuchlik S, Sekac J, Hlavaty T. Impact of smoking cigarette on the mRNA expression of cytokines in mucosa of inflammatory bowel disease. Physiol Res 2019;68:S183-92. [PMID: 31842582 DOI: 10.33549/physiolres.934301] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Stopfer P, Männel DN, Hehlgans T. Lymphotoxin-beta receptor activation by activated T cells induces cytokine release from mouse bone marrow-derived mast cells. J Immunol 2004;172:7459-65. [PMID: 15187124 DOI: 10.4049/jimmunol.172.12.7459] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 3.2] [Reference Citation Analysis]
30 Feng LR, Fernández-Martínez JL, Zaal KJM, deAndrés-Galiana EJ, Wolff BS, Saligan LN. mGluR5 mediates post-radiotherapy fatigue development in cancer patients. Transl Psychiatry 2018;8:110. [PMID: 29849049 DOI: 10.1038/s41398-018-0161-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
31 Proudfoot AE, Shaw JP, Power CA, Wells TN. Chemokines. Universes in Delicate Balance. Elsevier; 2002. pp. 65-85. [DOI: 10.1016/b978-044451002-0/50006-3] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
32 Neves BM, Cruz MT, Francisco V, Garcia-rodriguez C, Silvestre R, Cordeiro-da-silva A, Dinis AM, Batista MT, Duarte CB, Lopes MC. Differential roles of PI3-Kinase, MAPKs and NF-κB on the manipulation of dendritic cell Th1/Th2 cytokine/chemokine polarizing profile. Molecular Immunology 2009;46:2481-92. [DOI: 10.1016/j.molimm.2009.05.021] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 3.4] [Reference Citation Analysis]
33 Kucuk C, Sozuer E, Gursoy S, Canoz O, Artis T, Akcan A, Akyildiz H, Muhtaroglu S. Treatment with Met-RANTES decreases bacterial translocation in experimental colitis. Am J Surg. 2006;191:77-83. [PMID: 16399111 DOI: 10.1016/j.amjsurg.2005.10.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
34 Yoshida M, Shirai Y, Watanabe T, Yamori M, Iwakura Y, Chiba T, Kita T, Wakatsuki Y. Differential localization of colitogenic Th1 and Th2 cells monospecific to a microflora-associated antigen in mice. Gastroenterology. 2002;123:1949-1961. [PMID: 12454852 DOI: 10.1053/gast.2002.37049] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
35 Eijkelkamp N, Heijnen CJ, Lucas A, Premont RT, Elsenbruch S, Schedlowski M, Kavelaars A. G protein-coupled receptor kinase 6 controls chronicity and severity of dextran sodium sulphate-induced colitis in mice. Gut. 2007;56:847-854. [PMID: 17229795 DOI: 10.1136/gut.2006.107094] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
36 Ansari N, Abdulla J, Zayyani N, Brahmi U, Taha S, Satir AA. Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis? J Clin Pathol 2006;59:1066-72. [PMID: 16565224 DOI: 10.1136/jcp.2005.034983] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
37 Parhar K, Ray A, Steinbrecher U, Nelson C, Salh B. The p38 mitogen-activated protein kinase regulates interleukin-1beta-induced IL-8 expression via an effect on the IL-8 promoter in intestinal epithelial cells. Immunology 2003;108:502-12. [PMID: 12667212 DOI: 10.1046/j.1365-2567.2003.01603.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 2.8] [Reference Citation Analysis]
38 Proudfoot AE, Bonvin P, Power CA. Targeting chemokines: Pathogens can, why can't we? Cytokine 2015;74:259-67. [PMID: 25753743 DOI: 10.1016/j.cyto.2015.02.011] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 7.3] [Reference Citation Analysis]
39 Yan J, Zuo G, Sherchan P, Huang L, Ocak U, Xu W, Travis ZD, Wang W, Zhang JH, Tang J. CCR1 Activation Promotes Neuroinflammation Through CCR1/TPR1/ERK1/2 Signaling Pathway After Intracerebral Hemorrhage in Mice. Neurotherapeutics 2020;17:1170-83. [PMID: 31898284 DOI: 10.1007/s13311-019-00821-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
40 Chen MC, Keshavan P, Gregory GD, Klumpp DJ. RANTES mediates TNF-dependent lamina propria mast cell accumulation and barrier dysfunction in neurogenic cystitis. Am J Physiol Renal Physiol 2007;292:F1372-9. [PMID: 17244892 DOI: 10.1152/ajprenal.00472.2006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
41 Ferhat M, Hablot J, Taieb M, Salem F, Netter P, Peyrin-Biroulet L, Jouzeau JY, Moulin D. Lack of protective effect of CCR3 blockade during experimental colitis may be related to CCR3 expression by colonic Tregs. Clin Transl Med 2021;11:e455. [PMID: 34185413 DOI: 10.1002/ctm2.455] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Ajuebor MN, Zagorski J, Kunkel SL, Strieter RM, Hogaboam CM. Contrasting roles for CXCR2 during experimental colitis. Exp Mol Pathol. 2004;76:1-8. [PMID: 14738862 DOI: 10.1016/j.yexmp.2003.08.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
43 Vogel JD, West GA, Danese S, De La Motte C, Phillips MH, Strong SA, Willis J, Fiocchi C. CD40-mediated immune-nonimmune cell interactions induce mucosal fibroblast chemokines leading to T-cell transmigration. Gastroenterology. 2004;126:63-80. [PMID: 14699489 DOI: 10.1053/j.gastro.2003.10.046] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 3.0] [Reference Citation Analysis]
44 Hillman M, Weström B, Aalaei K, Erlanson-Albertsson C, Wolinski J, Lozinska L, Sjöholm I, Rayner M, Landin-Olsson M. Skim milk powder with high content of Maillard reaction products affect weight gain, organ development and intestinal inflammation in early life in rats. Food Chem Toxicol 2019;125:78-84. [PMID: 30553875 DOI: 10.1016/j.fct.2018.12.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
45 Takahara Y, Takahashi M, Wagatsuma H, Yokoya F, Zhang QW, Yamaguchi M, Aburatani H, Kawada N. Gene expression profiles of hepatic cell-type specific marker genes in progression of liver fibrosis. World J Gastroenterol 2006; 12(40): 6473-6499 [PMID: 17072980 DOI: 10.3748/wjg.v12.i40.6473] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
46 Hang LH, Shao DH, Chen Z, Chen YF, Shu WW, Zhao ZG. Involvement of spinal CC chemokine ligand 5 in the development of bone cancer pain in rats. Basic Clin Pharmacol Toxicol 2013;113:325-8. [PMID: 23773283 DOI: 10.1111/bcpt.12099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.1] [Reference Citation Analysis]
47 Choi SW, Hildebrandt GC, Olkiewicz KM, Hanauer DA, Chaudhary MN, Silva IA, Rogers CE, Deurloo DT, Fisher JM, Liu C, Adams D, Chensue SW, Cooke KR. CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantation. Blood 2007;110:3447-55. [PMID: 17641205 DOI: 10.1182/blood-2007-05-087403] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
48 Liou JT, Lee CM, Day YJ. The immune aspect in neuropathic pain: role of chemokines. Acta Anaesthesiol Taiwan 2013;51:127-32. [PMID: 24148742 DOI: 10.1016/j.aat.2013.08.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
49 Dotan I, Mayer L. Immunopathogenesis of inflammatory bowel disease. Curr Opin Gastroenterol. 2002;18:421-427. [PMID: 17033316 DOI: 10.1097/00001574-200207000-00005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
50 Parhar K, Ray A, Steinbrecher U, Nelson C, Salh B. The p38 mitogen-activated protein kinase regulates interleukin-1beta-induced IL-8 expression via an effect on the IL-8 promoter in intestinal epithelial cells. Immunology. 2003;108:502-512. [PMID: 12667212 DOI: 10.1046/i.1365-2567.2003.01603.x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Zhang W, Rhodes SD, Zhao L, He Y, Zhang Y, Shen Y, Yang D, Wu X, Li X, Yang X, Park SJ, Chen S, Turner C, Yang FC. Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model. Bone 2011;48:1378-87. [PMID: 21439418 DOI: 10.1016/j.bone.2011.03.760] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
52 Beaudette-zlatanova BC, Whalen B, Zipris D, Yagita H, Rozing J, Groen H, Benjamin CD, Hunig T, Drexhage HA, Ansari MJ, Leif J, Mordes JP, Greiner DL, Sayegh MH, Rossini AA. Costimulation and Autoimmune Diabetes in BB Rats: Costimulation and Diabetes in BB Rats. American Journal of Transplantation 2006;6:894-902. [DOI: 10.1111/j.1600-6143.2005.01227.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
53 Souza-Fonseca-Guimaraes F, Krasnova Y, Putoczki T, Miles K, MacDonald KP, Town L, Shi W, Gobe GC, McDade L, Mielke LA. Granzyme M has a critical role in providing innate immune protection in ulcerative colitis. Cell Death Dis. 2016;7:e2302. [PMID: 27441655 DOI: 10.1038/cddis.2016.215] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
54 Wu X, Chen S, He Y, Rhodes SD, Mohammad KS, Li X, Yang X, Jiang L, Nalepa G, Snider P, Robling AG, Clapp DW, Conway SJ, Guise TA, Yang FC. The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1. PLoS One 2011;6:e24917. [PMID: 21980365 DOI: 10.1371/journal.pone.0024917] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
55 Barnes SL, Vidrich A, Wang ML, Wu GD, Cominelli F, Rivera-Nieves J, Bamias G, Cohn SM. Resistin-like molecule beta (RELMbeta/FIZZ2) is highly expressed in the ileum of SAMP1/YitFc mice and is associated with initiation of ileitis. J Immunol 2007;179:7012-20. [PMID: 17982092 DOI: 10.4049/jimmunol.179.10.7012] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
56 Conway KL, Goel G, Sokol H, Manocha M, Mizoguchi E, Terhorst C, Bhan AK, Gardet A, Xavier RJ. p40phox expression regulates neutrophil recruitment and function during the resolution phase of intestinal inflammation. J Immunol 2012;189:3631-40. [PMID: 22914050 DOI: 10.4049/jimmunol.1103746] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
57 Lindsay J, Van Montfrans C, Brennan F, Van Deventer S, Drillenburg P, Hodgson H, Te Velde A, Sol Rodriguez Pena M. IL-10 gene therapy prevents TNBS-induced colitis. Gene Ther. 2002;9:1715-1721. [PMID: 12457286 DOI: 10.1038/sj.gt.3301841] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 3.1] [Reference Citation Analysis]
58 Shahrara S, Proudfoot AE, Woods JM, Ruth JH, Amin MA, Park CC, Haas CS, Pope RM, Haines GK, Zha YY, Koch AE. Amelioration of rat adjuvant-induced arthritis by Met-RANTES. Arthritis Rheum 2005;52:1907-19. [PMID: 15934086 DOI: 10.1002/art.21033] [Cited by in Crossref: 86] [Cited by in F6Publishing: 82] [Article Influence: 5.4] [Reference Citation Analysis]
59 Mao SH, Feng DD, Wang X, Zhi YH, Lei S, Xing X, Jiang RL, Wu JN. Magnolol protects against acute gastrointestinal injury in sepsis by down-regulating regulated on activation, normal T-cell expressed and secreted. World J Clin Cases 2021; 9(34): 10451-10463 [DOI: 10.12998/wjcc.v9.i34.10451] [Reference Citation Analysis]
60 Sabbatini M, Bosetti M, Borrone A, Moalem L, Taveggia A, Verna G, Cannas M. Erythropoietin stimulation of human adipose tissue for therapeutic refilling releases protective cytokines. J Tissue Eng 2016;7:2041731416671278. [PMID: 27738510 DOI: 10.1177/2041731416671278] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
61 Kashfi K, Olson KR. Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras. Biochem Pharmacol 2013;85:689-703. [PMID: 23103569 DOI: 10.1016/j.bcp.2012.10.019] [Cited by in Crossref: 192] [Cited by in F6Publishing: 186] [Article Influence: 21.3] [Reference Citation Analysis]
62 Yun JJ, Whiting D, Fischbein MP, Banerji A, Irie Y, Stein D, Fishbein MC, Proudfoot AE, Laks H, Berliner JA. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection. Circulation. 2004;109:932-937. [PMID: 14757698 DOI: 10.1161/01.cir.0000112595.65972.8a] [Cited by in Crossref: 69] [Cited by in F6Publishing: 11] [Article Influence: 4.1] [Reference Citation Analysis]
63 Morteau O, Castagliuolo I, Mykoniatis A, Zacks J, Wlk M, Lu B, Akis CP, Gerard NP, Gerard C. Genetic deficiency in the chemokine receptor CCR1 protects against acute clostridium difficile toxin A enteritis in mice. Gastroenterology 2002;122:725-33. [DOI: 10.1053/gast.2002.31873] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
64 Motavallian A, Minaiyan M, Rabbani M, Mahzouni P, Andalib S. Anti-inflammatory effects of alosetron mediated through 5-HT3 receptors on experimental colitis. Res Pharm Sci 2019;14:228-36. [PMID: 31160900 DOI: 10.4103/1735-5362.258489] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
65 Danese S, Gasbarrini A. Chemokines in inflammatory bowel disease. J Clin Pathol 2005;58:1025-7. [PMID: 16189145 DOI: 10.1136/jcp.2005.030916] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.0] [Reference Citation Analysis]
66 Herfarth H, Pollok-Kopp B, Göke M, Press A, Oppermann M. Polymorphism of CC chemokine receptors CCR2 and CCR5 in Crohn's disease. Immunol Lett 2001;77:113-7. [PMID: 11377705 DOI: 10.1016/s0165-2478(01)00199-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
67 Fiorucci S, Orlandi S, Mencarelli A, Caliendo G, Santagada V, Distrutti E, Santucci L, Cirino G, Wallace JL. Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br J Pharmacol 2007;150:996-1002. [PMID: 17339831 DOI: 10.1038/sj.bjp.0707193] [Cited by in Crossref: 157] [Cited by in F6Publishing: 153] [Article Influence: 11.2] [Reference Citation Analysis]
68 Blanchard C, Rothenberg ME. Biology of the eosinophil. Adv Immunol. 2009;101:81-121. [PMID: 19231593 DOI: 10.1016/s0065-2776(08)01003-1] [Cited by in Crossref: 214] [Cited by in F6Publishing: 89] [Article Influence: 17.8] [Reference Citation Analysis]
69 Russler-Germain EV, Jung J, Miller AT, Young S, Yi J, Wehmeier A, Fox LE, Monte KJ, Chai JN, Kulkarni DH, Funkhouser-Jones LJ, Wilke G, Durai V, Zinselmeyer BH, Czepielewski RS, Greco S, Murphy KM, Newberry RD, Sibley LD, Hsieh CS. Commensal Cryptosporidium colonization elicits a cDC1-dependent Th1 response that promotes intestinal homeostasis and limits other infections. Immunity 2021;54:2547-2564.e7. [PMID: 34715017 DOI: 10.1016/j.immuni.2021.10.002] [Reference Citation Analysis]
70 Ajuebor MN, Swain MG. Role of chemokines and chemokine receptors in the gastrointestinal tract. Immunology. 2002;105:137-143. [PMID: 11872088 DOI: 10.1046/j.1365-2567.2002.01309.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 3.8] [Reference Citation Analysis]
71 Wen T, Li Y, Wu M, Chen X, Han L, Bao X, Wang Z, Wang K, Hu Y, Zhou X, Wu Z, Wang P, Hong Z, Zhao L, Wang Q, Yin Z. A novel tylophorine analog NK-007 ameliorates colitis through inhibition of innate immune response. Int Immunopharmacol 2012;14:487-94. [PMID: 22929538 DOI: 10.1016/j.intimp.2012.08.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
72 Akyildiz H, Akcan A, Sozuer E, Kucuk C, Yilmaz N, Deniz K. The preventive effect of Met-RANTES on postoperative intraperitoneal adhesion formation in the rat model. Surgery. 2008;144:404-409. [PMID: 18707039 DOI: 10.1016/j.surg.2008.04.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
73 Ajuebor MN, Wondimu Z, Hogaboam CM, Le T, Proudfoot AE, Swain MG. CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitis. Am J Pathol 2007;170:1975-88. [PMID: 17525265 DOI: 10.2353/ajpath.2007.060690] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 4.6] [Reference Citation Analysis]
74 Pastore S, Cavani A, Albanesi C, Girolomoni G. Chemokines of Human Skin. In: Bos J, editor. Skin Immune System. CRC Press; 2004. pp. 373-92. [DOI: 10.1201/b14248-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
75 Anand PK, Kanneganti TD. NLRP6 in infection and inflammation. Microbes Infect 2013;15:661-8. [PMID: 23811097 DOI: 10.1016/j.micinf.2013.06.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
76 Rosbottom A, Knight PA, Mclachlan G, Thornton EM, Wright SW, Miller HRP, Scudamore CL. Chemokine and cytokine expression in murine intestinal epithelium following Nippostrongylus brasiliensis infection. Parasite Immunol 2002;24:67-75. [DOI: 10.1046/j.0141-9838.2001.00437.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]
77 Oki M, Ohtani H, Kinouchi Y, Sato E, Nakamura S, Matsumoto T, Nagura H, Yoshie O, Shimosegawa T. Accumulation of CCR5+ T cells around RANTES+ granulomas in Crohn's disease: a pivotal site of Th1-shifted immune response? Lab Invest 2005;85:137-45. [DOI: 10.1038/labinvest.3700189] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.2] [Reference Citation Analysis]
78 Lindborg JA, Mack M, Zigmond RE. Neutrophils Are Critical for Myelin Removal in a Peripheral Nerve Injury Model of Wallerian Degeneration. J Neurosci. 2017;37:10258-10277. [PMID: 28912156 DOI: 10.1523/jneurosci.2085-17.2017] [Cited by in Crossref: 61] [Cited by in F6Publishing: 46] [Article Influence: 15.3] [Reference Citation Analysis]
79 Liou J, Mao C, Ching-wah Sum D, Liu F, Lai Y, Li J, Day Y. Peritoneal Administration of Met-RANTES Attenuates Inflammatory and Nociceptive Responses in a Murine Neuropathic Pain Model. The Journal of Pain 2013;14:24-35. [DOI: 10.1016/j.jpain.2012.09.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
80 Chou CC, Fine JS, Pugliese-Sivo C, Gonsiorek W, Davies L, Deno G, Petro M, Schwarz M, Zavodny PJ, Hipkin RW. Pharmacological characterization of the chemokine receptor, hCCR1 in a stable transfectant and differentiated HL-60 cells: antagonism of hCCR1 activation by MIP-1beta. Br J Pharmacol 2002;137:663-75. [PMID: 12381680 DOI: 10.1038/sj.bjp.0704907] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
81 Huang Y, Jiao S, Tao X, Tang Q, Jiao W, Xiao J, Xu X, Zhang Y, Liang G, Wang H. Met-CCL5 represents an immunotherapy strategy to ameliorate rabies virus infection. J Neuroinflammation 2014;11:146. [PMID: 25182681 DOI: 10.1186/s12974-014-0146-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
82 Kristensen NN, Brudzewsky D, Gad M, Claesson MH. Chemokines involved in protection from colitis by CD4+CD25+ regulatory T cells. Inflamm Bowel Dis 2006;12:612-8. [PMID: 16804399 DOI: 10.1097/01.ibd.0000225342.44850.d5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
83 Nunes NS, Kim S, Sundby M, Chandran P, Burks SR, Paz AH, Frank JA. Temporal clinical, proteomic, histological and cellular immune responses of dextran sulfate sodium-induced acute colitis. World J Gastroenterol 2018; 24(38): 4341-4355 [PMID: 30344419 DOI: 10.3748/wjg.v24.i38.4341] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
84 Chvatchko Y, Proudfoot AE, Buser R, Juillard P, Alouani S, Kosco-Vilbois M, Coyle AJ, Nibbs RJ, Graham G, Offord RE, Wells TN. Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3. J Immunol 2003;171:5498-506. [PMID: 14607956 DOI: 10.4049/jimmunol.171.10.5498] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
85 Carollo M, Hogaboam CM, Kunkel SL, Delaney S, Christie MI, Perretti M. Analysis of the temporal expression of chemokines and chemokine receptors during experimental granulomatous inflammation: role and expression of MIP-1alpha and MCP-1. Br J Pharmacol 2001;134:1166-79. [PMID: 11704636 DOI: 10.1038/sj.bjp.0704371] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
86 D'Ambrosio D, Panina-Bordignon P, Sinigaglia F. Chemokine receptors in inflammation: an overview. J Immunol Methods 2003;273:3-13. [PMID: 12535793 DOI: 10.1016/s0022-1759(02)00414-3] [Cited by in Crossref: 118] [Cited by in F6Publishing: 36] [Article Influence: 6.6] [Reference Citation Analysis]
87 Repeke CE, Ferreira SB Jr, Vieira AE, Silveira EM, Avila-Campos MJ, da Silva JS, Santos CF, Campanelli AP, Trombone AP, Garlet GP. Dose-response met-RANTES treatment of experimental periodontitis: a narrow edge between the disease severity attenuation and infection control. PLoS One 2011;6:e22526. [PMID: 21799885 DOI: 10.1371/journal.pone.0022526] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
88 Barcelos LS, Coelho AM, Russo RC, Guabiraba R, Souza AL, Bruno-Lima G, Proudfoot AE, Andrade SP, Teixeira MM. Role of the chemokines CCL3/MIP-1 alpha and CCL5/RANTES in sponge-induced inflammatory angiogenesis in mice. Microvasc Res. 2009;78:148-154. [PMID: 19427874 DOI: 10.1016/j.mvr.2009.04.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
89 Yu C, Zhang S, Wang Y, Zhang S, Luo L, Thorlacius H. Platelet-Derived CCL5 Regulates CXC Chemokine Formation and Neutrophil Recruitment in Acute Experimental Colitis. J Cell Physiol 2016;231:370-6. [PMID: 26089223 DOI: 10.1002/jcp.25081] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
90 Mateo T, Abu Nabah YN, Abu Taha M, Mata M, Cerdá-Nicolás M, Proudfoot AE, Stahl RA, Issekutz AC, Cortijo J, Morcillo EJ, Jose PJ, Sanz MJ. Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines. J Immunol 2006;176:5577-86. [PMID: 16622027 DOI: 10.4049/jimmunol.176.9.5577] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 4.7] [Reference Citation Analysis]
91 Bhavsar MD, Amiji MM. Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease. Gene Ther 2008;15:1200-9. [DOI: 10.1038/gt.2008.67] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 6.8] [Reference Citation Analysis]
92 Ajuebor MN, Kunkel SL, Hogaboam CM. The role of CCL3/macrophage inflammatory protein-1α in experimental colitis. European Journal of Pharmacology 2004;497:343-9. [DOI: 10.1016/j.ejphar.2004.07.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
93 Motavallian A, Minaiyan M, Rabbani M, Mahzouni P, Andalib S, Abed A, Babavalian MR. Does Cisapride, as a 5HT(4) Receptor Agonist, Aggravate the Severity of TNBS-Induced Colitis in Rat? Gastroenterol Res Pract 2012;2012:362536. [PMID: 22888336 DOI: 10.1155/2012/362536] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
94 Ness TL, Kunkel SL, Hogaboam CM. CCR5 antagonists: the answer to inflammatory disease? Expert Opinion on Therapeutic Patents 2006;16:1051-65. [DOI: 10.1517/13543776.16.8.1051] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
95 Ye X, Liu S, Hu M, Song Y, Huang H, Zhong Y. CCR5 expression in inflammatory bowel disease and its correlation with inflammatory cells and β-arrestin2 expression. Scand J Gastroenterol 2017;52:551-7. [PMID: 28140695 DOI: 10.1080/00365521.2017.1281435] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
96 Pender SL, Chance V, Whiting CV, Buckley M, Edwards M, Pettipher R, MacDonald TT. Systemic administration of the chemokine macrophage inflammatory protein 1alpha exacerbates inflammatory bowel disease in a mouse model. Gut. 2005;54:1114-1120. [PMID: 16009684 DOI: 10.1136/gut.2004.052779] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
97 Carter PH. Chemokine receptor antagonism as an approach to anti-inflammatory therapy: 'just right' or plain wrong? Curr Opin Chem Biol 2002;6:510-25. [PMID: 12133728 DOI: 10.1016/s1367-5931(02)00351-4] [Cited by in Crossref: 47] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
98 Henderson AL, Brand MW, Darling RJ, Maas KJ, Detzel CJ, Hostetter J, Wannemuehler MJ, Weaver EM. Attenuation of Colitis by Serum-Derived Bovine Immunoglobulin/Protein Isolate in a Defined Microbiota Mouse Model. Dig Dis Sci 2015;60:3293-303. [PMID: 26026602 DOI: 10.1007/s10620-015-3726-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
99 Proudfoot AE. Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol. 2002;2:106-115. [PMID: 11910892 DOI: 10.1038/nri722] [Cited by in Crossref: 501] [Cited by in F6Publishing: 471] [Article Influence: 26.4] [Reference Citation Analysis]
100 Papadakis KA. Chemokines in inflammatory bowel disease. Curr Allergy Asthma Rep 2004;4:83-9. [PMID: 14680627 DOI: 10.1007/s11882-004-0048-7] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 3.5] [Reference Citation Analysis]
101 Danese S, de la Motte C, Sturm A, Vogel JD, West GA, Strong SA, Katz JA, Fiocchi C. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology 2003;124:1249-64. [PMID: 12730866 DOI: 10.1016/s0016-5085(03)00289-0] [Cited by in Crossref: 139] [Cited by in F6Publishing: 53] [Article Influence: 7.7] [Reference Citation Analysis]
102 Xu Y, Feng D, Wang Y, Lin S, Xu L. Sodium tanshinone IIA sulfonate protects mice from ConA-induced hepatitis via inhibiting NF-kappaB and IFN-gamma/STAT1 pathways. J Clin Immunol 2008;28:512-9. [PMID: 18498044 DOI: 10.1007/s10875-008-9206-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]